Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Hardy

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Acta Crystallographica. Section F, Structural Biology Communications|March 7, 2014
Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362Sophie E Broughton, Timothy R Hercus, Tracy L Nero, et al.
BMC Genomics|March 5, 2020
Expert curation of the human and mouse olfactory receptor gene repertoires identifies conserved coding regions split across two exonsIf H A Barnes, Ximena Ibarra-Soria, Stephen Fitzgerald, et al.
International Journal of Molecular Sciences|July 26, 2018
Mining the Plasma Cell Transcriptome for Novel Cell Surface ProteinsStephanie Trezise, Alexander Karnowski, Pasquale L Fedele, et al.
Molecular Pharmaceutics|July 22, 2021
Modular Platform for the Development of Recombinant Hemoglobin Scavenger BiotherapeuticsRaphael M Buzzi, Catherine M Owczarek, Kevin Akeret, et al.
Science Translational Medicine|February 7, 2014
A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding riskMagnus Larsson, Veronika Rayzman, Marc W Nolte, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2021
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIIIJenny Chia, Sabine Pestel, Isabelle Glauser, et al.
Nature Communications|January 28, 2018
A dual role for the N-terminal domain of the IL-3 receptor in cell signallingSophie E Broughton, Timothy R Hercus, Tracy L Nero, et al.
The Biochemical Journal|April 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.
International Journal of Molecular Sciences|March 14, 2026
CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRnSandra Wymann, Rodrigo A V Morales, Wei Hong Toh, et al.
Cell Reports|July 22, 2014
Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibodySophie E Broughton, Timothy R Hercus, Matthew P Hardy, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Acta Crystallographica. Section F, Structural Biology Communications|March 7, 2014
Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362Sophie E Broughton, Timothy R Hercus, Tracy L Nero, et al.
BMC Genomics|March 5, 2020
Expert curation of the human and mouse olfactory receptor gene repertoires identifies conserved coding regions split across two exonsIf H A Barnes, Ximena Ibarra-Soria, Stephen Fitzgerald, et al.
International Journal of Molecular Sciences|July 26, 2018
Mining the Plasma Cell Transcriptome for Novel Cell Surface ProteinsStephanie Trezise, Alexander Karnowski, Pasquale L Fedele, et al.
Molecular Pharmaceutics|July 22, 2021
Modular Platform for the Development of Recombinant Hemoglobin Scavenger BiotherapeuticsRaphael M Buzzi, Catherine M Owczarek, Kevin Akeret, et al.
Science Translational Medicine|February 7, 2014
A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding riskMagnus Larsson, Veronika Rayzman, Marc W Nolte, et al.
Journal of Thrombosis and Haemostasis : JTH|August 1, 2021
Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIIIJenny Chia, Sabine Pestel, Isabelle Glauser, et al.
Nature Communications|January 28, 2018
A dual role for the N-terminal domain of the IL-3 receptor in cell signallingSophie E Broughton, Timothy R Hercus, Tracy L Nero, et al.
The Biochemical Journal|April 26, 2022
Sialylation-dependent pharmacokinetics and differential complement pathway inhibition are hallmarks of CR1 activity in vivoSandra Wymann, Marcel Mischnik, David Leong, et al.
International Journal of Molecular Sciences|March 14, 2026
CSL305: A Dual Functional Therapeutic Antibody Targeting Complement C2 and FcRnSandra Wymann, Rodrigo A V Morales, Wei Hong Toh, et al.
Cell Reports|July 22, 2014
Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibodySophie E Broughton, Timothy R Hercus, Matthew P Hardy, et al.
Pageof 9